UNLABELLED: The effect of quercetin C-glucoside (QCG) on osteoblast function in vitro and bone formation in vivo was investigated. QCG supplementation promoted peak bone mass achievement in growing rats and new bone formation in osteopenic rats. QCG has substantial oral bioavailability. Findings suggest a significant bone anabolic effect of QCG. INTRODUCTION: Recently, we showed that extracts of Ulmus wallichiana promoted peak bone mass achievement in growing rats and preserved trabecular bone mass and cortical bone strength in ovariectomized (OVx) rats. 3,3',4',5,7-Pentahydroxyflavone-6-C-β-D-glucopyranoside, a QCG, is the most abundant bioactive compound of U. wallichiana extract. We hypothesize that QCG exerts bone anabolic effects by stimulating osteoblast function. METHODS: Osteoblast cultures were harvested from rat calvaria and bone marrow (BM) to study differentiation and mineralization. In vivo, growing female Sprague Dawley rats and OVx rats with osteopenia were administered QCG (5.0 or 10.0 mg kg(-1) day(-1)) orally for 12 weeks. Efficacy was evaluated by examining changes in bone microarchitecture using histomorphometric and microcomputed tomographic analyses and by determination of new bone formation by fluorescent labeling of bone. Plasma and BM levels of QCG were determined by high-performance liquid chromatography. RESULTS: QCG was much more potent than quercetin (Q) in stimulating osteoblast differentiation, and the effect of QCG was not mediated by estrogen receptors. In growing rats, QCG increased BM osteoprogenitors, bone mineral density, bone formation rate, and cortical deposition. In osteopenic rats, QCG treatment increased bone formation rate and improved trabecular microarchitecture. Comparison with the sham group (ovary intact) revealed significant restoration of trabecular bone in osteopenic rats treated with QCG. QCG levels in the BM were ~50% of that of the plasma levels. CONCLUSION: QCG stimulated modeling-directed bone accrual and exerted anabolic effects on osteopenic rats by direct stimulatory effect on osteoprogenitors likely due to substantial QCG delivery at tissue level following oral administration.
UNLABELLED: The effect of quercetin C-glucoside (QCG) on osteoblast function in vitro and bone formation in vivo was investigated. QCG supplementation promoted peak bone mass achievement in growing rats and new bone formation in osteopenicrats. QCG has substantial oral bioavailability. Findings suggest a significant bone anabolic effect of QCG. INTRODUCTION: Recently, we showed that extracts of Ulmus wallichiana promoted peak bone mass achievement in growing rats and preserved trabecular bone mass and cortical bone strength in ovariectomized (OVx) rats. 3,3',4',5,7-Pentahydroxyflavone-6-C-β-D-glucopyranoside, a QCG, is the most abundant bioactive compound of U. wallichiana extract. We hypothesize that QCG exerts bone anabolic effects by stimulating osteoblast function. METHODS: Osteoblast cultures were harvested from rat calvaria and bone marrow (BM) to study differentiation and mineralization. In vivo, growing female Sprague Dawley rats and OVx rats with osteopenia were administered QCG (5.0 or 10.0 mg kg(-1) day(-1)) orally for 12 weeks. Efficacy was evaluated by examining changes in bone microarchitecture using histomorphometric and microcomputed tomographic analyses and by determination of new bone formation by fluorescent labeling of bone. Plasma and BM levels of QCG were determined by high-performance liquid chromatography. RESULTS: QCG was much more potent than quercetin (Q) in stimulating osteoblast differentiation, and the effect of QCG was not mediated by estrogen receptors. In growing rats, QCG increased BM osteoprogenitors, bone mineral density, bone formation rate, and cortical deposition. In osteopenicrats, QCG treatment increased bone formation rate and improved trabecular microarchitecture. Comparison with the sham group (ovary intact) revealed significant restoration of trabecular bone in osteopenicrats treated with QCG. QCG levels in the BM were ~50% of that of the plasma levels. CONCLUSION: QCG stimulated modeling-directed bone accrual and exerted anabolic effects on osteopenicrats by direct stimulatory effect on osteoprogenitors likely due to substantial QCG delivery at tissue level following oral administration.
Authors: E Legrand; D Chappard; C Pascaretti; M Duquenne; S Krebs; V Rohmer; M F Basle; M Audran Journal: J Bone Miner Res Date: 2000-01 Impact factor: 6.741
Authors: Kunal Sharan; Jawed A Siddiqui; Gaurav Swarnkar; Abdul Malik Tyagi; Avinash Kumar; Preeti Rawat; Manmeet Kumar; Geet K Nagar; Kamal R Arya; Lakshmi Manickavasagam; Girish K Jain; Rakesh Maurya; Naibedya Chattopadhyay Journal: Menopause Date: 2010-03 Impact factor: 2.953
Authors: Sébastien A Gittens; Gregory R Wohl; Ronald F Zernicke; John R Matyas; Paul Morley; Hasan Uludag Journal: J Pharm Pharm Sci Date: 2004-01-30 Impact factor: 2.327
Authors: Teresita Bellido; A Afshan Ali; Lilian I Plotkin; Qiang Fu; Igor Gubrij; Paula K Roberson; Robert S Weinstein; Charles A O'Brien; Stavros C Manolagas; Robert L Jilka Journal: J Biol Chem Date: 2003-10-01 Impact factor: 5.157
Authors: Mohammad Shahnazari; Russell T Turner; Urszula T Iwaniec; Thomas J Wronski; Min Li; Mario G Ferruzzi; Robert A Nissenson; Bernard P Halloran Journal: J Nutr Biochem Date: 2016-05-10 Impact factor: 6.048
Authors: K Khan; K Sharan; G Swarnkar; B Chakravarti; M Mittal; T K Barbhuyan; S P China; M P Khan; G K Nagar; D Yadav; P Dixit; R Maurya; N Chattopadhyay Journal: Osteoporos Int Date: 2012-08-30 Impact factor: 4.507
Authors: Karl F Braun; Sabrina Ehnert; Thomas Freude; José T Egaña; Thilo L Schenck; Arne Buchholz; Andreas Schmitt; Sebastian Siebenlist; Lilianna Schyschka; Markus Neumaier; Ulrich Stöckle; Andreas K Nussler Journal: ScientificWorldJournal Date: 2011-11-30
Authors: Jawed A Siddiqui; Joshua Johnson; Carole Le Henaff; Claudine L Bitel; Joseph A Tamasi; Nicola C Partridge Journal: Sci Rep Date: 2017-11-10 Impact factor: 4.379
Authors: V Khedgikar; P Kushwaha; J Gautam; A Verma; B Changkija; A Kumar; S Sharma; G K Nagar; D Singh; P K Trivedi; N S Sangwan; P R Mishra; R Trivedi Journal: Cell Death Dis Date: 2013-08-22 Impact factor: 8.469
Authors: Leslie A Nash; Sandra J Peters; Philip J Sullivan; Wendy E Ward Journal: Int J Environ Res Public Health Date: 2016-04-29 Impact factor: 3.390